Who is sponsoring NCT01047189?

NCT01047189 is sponsored by Wake Forest University.

What condition does NCT01047189 study?

NCT01047189 studies Acne Vulgaris.

What drugs are being tested in NCT01047189?

Interventions: clindamycin phosphate 1.2% and tretinoin 0.025%, clindamycin 1% gel, tretinoin 0.025% cream.

What is the status of NCT01047189?

NCT01047189 is currently COMPLETED.

Last reviewed 2018-08-09 · How we verify

Adherence to ZIANA (Clindamycin Phosphate 1.2% With Tretinoin 0.025%)Gel Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris

NCT01047189 Phase 4 COMPLETED Results posted

The purpose of this research study is to evaluate the effectiveness of two different types of topical acne medication. This study will help to determine if one combined medication results in better acne improvement than two separate medications for acne.

Details

Lead sponsor	Wake Forest University
Phase	Phase 4
Status	COMPLETED
Enrolment	26
Start date	2009-03
Completion	2009-10

Conditions

Acne Vulgaris

Interventions

clindamycin phosphate 1.2% and tretinoin 0.025%
clindamycin 1% gel
tretinoin 0.025% cream

Primary outcomes

Measured Adherence to ZIANA Gel or Generic Topical Clindamycin 1% Gel Each Morning Plus Generic Topical Tretinoin 0.025% Cream Each Evening in Subjects With Mild to Moderate Acne — 12 weeks
Percentage of prescribed doses taken as measured by a Medication Event Monitoring System (MEMS) cap

Countries

United States